Login to Your Account



QLT, Xenova Suffer Setback As Pivotal Tariquidar Trial Stopped

By Nuala Moran and Aaron Lorenzo


Wednesday, May 14, 2003
Development partners QLT Inc. and Xenova Group plc are going through a letdown after halting pivotal trials of tariquidar in non-small-cell lung cancer.(BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription